Diagnosis and management of growth disorders in Gulf Cooperation Council (GCC) countries: Current procedures and key recommendations for best practice

International Journal of Pediatrics and Adolescent Medicine

Abdullah S. Al Herbish¹  Mona Al Khawari²  Ekaterina Koledova³  Ahmed El-Awwa⁴  Angham Almutair⁵  Bassam Bin Abbas⁶  Afaf Alsagheir⁶  Asma Deeb⁷  Walid Kaplan⁸  Mohammed Alqahtani⁹  Martin O. Savage^1,10 

[1] Al Habib Medical Group, Saudi Arabia;Amiri Hospital, Kuwait;Global Medical Affairs Endocrinology, Merck KGaA, Darmstadt, Germany;Hamad Medical Corporation, Qatar and Alexandria Children's Hospital, Cairo, Egypt;King Abdullah Specialist Children's Hospital, King Saud bin Abdulaziz University for Health Science, Saudi Arabia;King Faisal Specialist Hospital and Research Centre, Saudi Arabia;Mafraq Hospital, Abu Dhabi, United Arab Emirates;Tawam Hospital, Al Ain, United Arab Emirates;University of Dammam, Saudi Arabia;William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, UK;

关键词: Growth disorders;    Growth hormone;    Insulin-like growth factor-1;    Adherence;    Transitional care;    Height screening;   

DOI  :  10.1016/j.ijpam.2016.07.002

来源: DOAJ

【 摘 要 】

Diagnosis and management of growth disorders comprises an important area of pediatric practice. Current procedures in the different stages of the identification, referral, investigation, and treatment of growth disorders in the Gulf Cooperation Council (GCC) countries have been summarized. Evidence-based procedures, relating specifically to height screening for identification of short stature, auxological criteria for patient referral from primary to secondary pediatric care, and general and endocrine investigations and diagnosis have been discussed and outlined. The management issues related to key disorders that are licensed for growth hormone (hGH) therapy, namely GH deficiency, Turner syndrome, short stature related to birth size small for gestational age (SGA), and idiopathic short stature are discussed with recommendations described for best practice. Finally, two key components of short stature management, namely transitional care for the transfer of patients from pediatric to adult endocrinology services and adherence to recommended therapy with hGH, have been addressed with current practice outlines and recommendations presented.

【 授权许可】

Unknown